GSK happy with 3 percent rise in 2017 sales
GlaxoSmithKline has reported a sales hike of 3 percent at constant exchange rates (CER*) for 2017, after growth was recorded across all of its three global businesses.
Read More
Tag: Triumeq
ViiV’s HIV therapy Triumeq shows efficacy in women
ViiV Healthcare’s Triumeq has come out on top in a late-stage study pitting its effectiveness in treating women with HIV against that of an atazanavir-based regimen.
Read More
- SolasCure trial shows faster healing with Aurase Wound Gel
- Gilead data show investigational HIV combination maintains viral suppression
- Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
- MHRA approves imlunestrant tosylate as new breast cancer treatment
- ACD440 granted orphan drug status in the EU
